Harald Hampel, MD, PhD | Psychiatrist.com

Original Research

Cortical Thickness Change During Donepezil Treatment in Suspected Prodromal Alzheimer's Disease

December 28, 2016

Cortical thinning, identified during prodromal Alzheimer's disease, is a "candidate" biomarker used in clinical therapy trials. This study looked at change in cortical thickness after 1 year of donepezil...

Harald Hampel, Enrica Cavedo, Bruno Dubois, et al

Academic Highlights

Long-Term Observation of a Multicomponent Cognitive Intervention in Mild Cognitive Impairment

December 15, 2012

Harald Hampel, Verena C. Buschert, Ina Giegling, et al

Article

Prediction of Alzheimer's Disease Using Midregional Proadrenomedullin and Midregional Proatrial Natriuretic Peptide: A Retrospective Analysis of 134 Patients With Mild Cognitive Impairment

November 2, 2010

Harald Hampel, Stefan J. Teipel, Katharina Buerger, et al

Original Research

Different Effects of Mirtazapine and Venlafaxine on Brain Activation: An Open Randomized Controlled fMRI Study

September 21, 2010

Hans-Jürgen Möller, Thomas Frodl, Johanna Scheuerecker, et al

Article

Lithium Trial in Alzheimer's Disease: A Randomized, Single-Blind, Placebo-Controlled, Multicenter 10-Week Study

June 18, 2009

Hans-Jürgen Möller, Harald Hampel, Michael Ewers, et al

Original Research

Pisa Syndrome (Pleurothotonus): Report of a Multicenter Drug Safety Surveillance Project

August 31, 2000

Hans-Jürgen Möller, Harald Hampel, Eckart Rüther, et al